Bryn Pharma Appointments Jeff Hartness to its Board of Directors
RALEIGH, N.C.–(BUSINESS WIRE)–Bryn Pharma LLC, a privately held pharmaceutical company dedicated to finding a better way for patients and caregivers to treat anaphylaxis, today announced the appointment of Jeff Hartness to its Board of Directors. Mr. Hartness joins a group of senior directors focused on commercialization. “Jeff’s diverse background crosses all channels and segments of […]
Go to Source
Powered by WPeMatico
